Project Data Sphere  News
  • Info @projectdatasphere > Project Data Sphere Initiative News

    Welcome to Amgen who have provided two new data sets in Breast and Prostate Cancer. Click here for Breast data: http://bit.ly/1yVV7as or Click here for Prostate data: http://bit.ly/1a5MNyv

    April 8 at 12:14 PM


  • Info @projectdatasphere > Project Data Sphere Initiative News

    Welcome to new data provider Synta who has provided our first Stage IV Melanoma data set by uploading its Elesclomol (STA-4783) with Paclitaxel Versus Paclitaxel Alone in Melanoma study. Click here to see data: http://bit.ly/1DnmAJj

    March 31 at 12:37 PM


  • Info @projectdatasphere > Project Data Sphere Initiative News

    The Prostate Cancer DREAM Challenge is now Live! See the Press Release here: http://bit.ly/18U1XGq . To register for the Challenge TODAY, please visit: http://bit.ly/1ADgksn

    March 17 at 11:11 AM


Researchers are working tirelessly and new advances are constantly being discovered, yet every day, tens of thousands of our loved ones lose their battle with cancer. Sadly, we're losing nearly the same number of people today as we were 40 years ago. With researchers working independently, we're simply not finding solutions quickly enough.

What if we could share, integrate, and analyze our collective historical cancer research data in a single location?

The Project Data Sphere  initiative provides an easy-to-use platform built to share, integrate, and analyze comparator arms of historical cancer trial data sets so we can learn from them and accelerate research. The Project Data Sphere  platform is available to researchers affiliated with life science companies, hospitals, and institutions, as well as independent researchers.

The true power of this platform will come from an ever increasing volume of data and the continuing engagement of a diverse global community focused on finding solutions for cancer patients.

Imagine what will happen when the entire cancer community joins efforts.


Get Involved

APPLY TO USE AND SHARE

SPREAD THE WORD